Table 2.
Overview of systematic reviews on COVID-19 outcomes in any mental disorders.
| Systematic reviews (search updated to) | N. original studies including psychiatric disorders | Primary COVID-19 Outcomes | Conclusion | AMSTAR 2 Quality |
|---|---|---|---|---|
| Fornaro et al. (24 Apr 2021) [14] | 1 | Infection | “The present scoping review confirmed the clinical suspicions about the overall vulnerability of people with a primary diagnosis of BD compared to the general population”. | Critically low |
| Karaoulanis and Christodoulou (21 Mar 2021) [12] | 4 | Infection | “People with schizophrenia spectrum disorders constitute a vulnerable group to COVID-19. Specifically, they suffer higher rates of infection and are more likely to die from COVID-19”. | Critically low |
| 5 | Mortality | |||
| Murthy and Narasimha (25 Nov 2020) [13] | 2 | Infection | “Multiple studies suggest alcohol increases the risk of COVID-19 infection”. | Critically low |